Microspheres for active embolization
First Claim
1. A microsphere suitable for active embolization comprising a biocompatible, cross-linked and substantially hydrophilic polymer and one or more active components comprising a drug, a vaccine, or any combination thereof.
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to injectable compositions comprising biocompatible, swellable, substantially hydrophilic, non-toxic and substantially spherical polymeric material carriers which are capable of efficiently delivering bioactive therapeutic factor(s) for use in embolization drug therapy. The present invention further relates to methods of embolization gene therapy, particularly for the treatment of angiogenic and non-angiogenic-dependent diseases, using the injectable compositions.
-
Citations
44 Claims
- 1. A microsphere suitable for active embolization comprising a biocompatible, cross-linked and substantially hydrophilic polymer and one or more active components comprising a drug, a vaccine, or any combination thereof.
- 26. A method for active embolization in a mammal comprising administering to a mammal in need of treatment a microsphere comprising a biocompatible, cross-linked and substantially hydrophilic polymer and one or more drugs, vaccines, or combinations thereof.
-
44. A method for active embolization in a mammal comprising administering to a mammal in need of treatment a microsphere comprising a biocompatible, cross-linked and substantially hydrophilic polymer and one or more drugs, vaccines, or combinations thereof, wherein said microsphere is delivered to the site of action by the use of targeting antibodies.
Specification